The DOI matches its Crossref record.
Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China
Open accessAbstract
To the Editor, A pneumonia of unknown pathogen that emerged in China had its first case announced in early December 2019 within Wuhan City, the capital of Hubei Province and one of the busiest and populated Chinese cities. The causative agent was identified as a novel coronavirus and named SARS‐CoV‐2. Patients infected by the SARS‐ CoV‐2 showed symptoms of fever and dyspnoea, lymphopenia, and ground‐glass lung changes in radiology. Severe cases developed life‐threatening complications, such as respiratory failure, shock, and multiple organs dysfunction. We report on an identified unique severe case involving co‐infection of SARS‐CoV‐2 and HIV. On 28 January 2020, a 61‐years‐old male from Hankou district of Wuhan reported recurrent fever and dry cough for 2 days went to a local fever clinic, which was setup for screening the SARS‐CoV‐ 2‐infected and suspected subjects. The patient was a heavy smoker of between 20 to 30 cigarettes a day. He had also been diagnosed with type II diabetes 2 year ago and received alogliptin co‐administered with metformin. The body temperature was 37.5°C. The clinic physician ordered blood routine test and chest computed tomography (CT), and was confirmed to have a mild lymphopenia with a lymphocyte count of 1.1 × 10/L. The chest CT indicated the SARS‐CoV‐2 pneumonia with findings of multiple ground‐glass opacities (GGO) in bilateral lungs (Figure 1A). He was kept in isolation at home and separated from his family members. Due to the shortage of the test kits, real‐time reverse‐ transcriptase polymerase chain reaction (RT‐PCR) assay for detection of coronavirus RNA was performed on his throat swabs on 3 February, which confirmed a positive result. From 1 to 4 February, apart from fever and cough, the patient developed shortness of breath. The follow‐ up Chest CT displayed progressive GGO and consolidation in lungs (Figure 1B). On 4 February, he was referred, quarantined and treated in Wuhan Tongji Sino‐French New Town Hospital, a designated medical institution for the novel coronavirus infection. On admission, physical examination revealed a body temperature of 39°C, respiratory rate of 30 breaths per minute and oxygen saturation of 80%, which reached 91% while the patient was given mask flow oxygen at a rate of 5 liters per minute. On supplemental oxygen, arterial blood gas analysis revealed: pH 7.41, PCO2 37.4 mm Hg, PO2 63.9 mm Hg, and − HCO3 23.4mmol/L. Lymphopenia also got worse, with a lymphocyte count of 0.56 × 10/L and a low CD4+ T‐lymphocyte percentage at 4.75%. An antigen/antibody combination test on blood gave HIV‐positive result. Oral therapy with an anti‐HIV drug, lopinavir/ritonavir 400/100mg per dose twice daily for 12 days, as was advised by Chinese health authority for the treatment of SARS‐ CoV‐2 infection, was started on admission. The patient also received moxifloxacin 400mg once daily for 7 days, γ‐globulin 400mg/kg once daily for 3 days, and methilprednisolone 0.8mg/kg once daily for 3 days through intravenous route. On 9 February, the patient showed a marked clinical and radiological improvement (Figure 1C). His oxygen saturation measured by pulse maintained above 95% on supplemental oxygen via nasal cannula at 2 liters per minute. Two additional throat swabs were obtained on 15 February and both were tested negative for SARS‐CoV‐2 RT‐PCR assay. The patient was in stable condition and discharged on 17 February. He was asked to keep isolated at home for two more weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lai, C.-C., Wang, C.-Y., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.05.013 · Cited by 489
COVID-19 in Africa: care and protection for frontline healthcare workers
Chersich, M. F., Gray, G., Fairlie, L., Eichbaum, Q., Mayhew, S., Allwood, B., English, R., Scorgie, F., Luchters, S., Simpson, G., et al. (2020) · Globalization and Health · doi:10.1186/s12992-020-00574-3 · Cited by 474
COVID-19 in patients with HIV: clinical case series
Blanco, J. L., Ambrosioni, J., Garcia, F., Martínez, E., Soriano, A., Mallolas, J., & Miro, J. M. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30111-9 · Cited by 414
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
Vizcarra, P., Pérez-Elías, M. J., Quereda, C., Moreno, A., Vivancos, M. J., Dronda, F., Casado, J. L., Moreno, S., Pérez-Elías, M. J., Fortún, J., et al. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30164-8 · Cited by 373
The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective
Shiau, S., Krause, K. D., Valera, P., Swaminathan, S., & Halkitis, P. N. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02871-9 · Cited by 349
COVID-19 Among People Living with HIV: A Systematic Review
Mirzaei, H., McFarland, W., Karamouzian, M., & Sharifi, H. (2021) · AIDS and Behavior · doi:10.1007/s10461-020-02983-2 · Cited by 260
EHA Infectious Disease Scientific Working Group, von Lilienfeld-Toal, M., Vehreschild, J. J., Cornely, O., Pagano, L., Compagno, F., & Hirsch, H. H. (2020) · Leukemia · doi:10.1038/s41375-020-0832-y · Cited by 55
Metadata
- Authors
- Zhu, F., Cao, Y., Xu, S., & Zhou, M.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-03-11
- Volume
- 92
- Issue
- 6
- Pages
- 529-530
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3009493119
- Cited by
- 179
- References
- 0
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.